Images
Participants
Contact
Several media have picked up on the launch of the new biotechnology company Nostrum BioDiscovery, a joint initiative between IRB Barcelona and the Barcelona Supercomputing Center-National Supercomputing Center (BSC-CNS). Modesto Orozco, group leader of the Molecular Modelling and Bioinformatics lab at IRB Barcelona, will chair the new spin-off, which aims to launch new drugs and biotech molecules developed using computational simulation.
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
